Aeris Biosciences raises $3.4M Seed (United States, Aug 2026)
Find the investors funding Health Seed rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Cleveland's Aeris Biosciences raises $3.4M seed to bring wound tech to humans - Dealroom
Aeris Biosciences is focused on developing innovative wound care technologies. The company aims to bring its advanced solutions to the human market, addressing significant needs in wound management. This funding round will support their efforts to commercialize their technology.
Cleveland's Aeris Biosciences raises $3.4M seed to bring wound tech to humans Dealroom
| Sep 23, 2026 | Ema | $77.0M | Series B | United States |
| Sep 23, 2026 | Baselayer | $35.0M | Series A | United States |
| Sep 23, 2026 | Hubble Network | $200.0M | Series C | United States |
| Sep 23, 2026 | Topdog | $2.5M | Seed | United States |
21,386 investors back startups in United States
You just read who funded Aeris Biosciences. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.